Sector pending / Drugs, Drug Proprietaries, and Druggists' SundriesUpdated 2026-05-10 22:07 UTC

FRA/CLH stock hub

FRA/CLH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/CLHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

36.5B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/CLH

In the news

Latest news · FRA/CLH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.7

P25 n/aP50 n/aP75 n/a

Trailing P/E27.1

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC81

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/CLH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

USD

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	55,392
Employees Change	8,800%
Employees Change Percent	18
Enterprise value	EUR 40.9B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drugs, Drug Proprietaries, and Druggists' Sundries
Last refreshed	2026-05-10
Market cap	EUR 36.5B
Price	EUR 157
Price currency	EUR
Rev Per Employee	3,925,882.18x
Sic	5122
Symbol	fra/CLH
Website	https://www.cardinalhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.69%
EV Earnings	30.33x
EV/EBIT	15.68x
EV/EBITDA	11.48x
EV/FCF	10.76x
EV/Sales	0.19x
FCF yield	10.41%
Forward P/E	15.73x
P/B ratio	-15.77x
P/E ratio	27.1x
P/S ratio	0.17x
PE Ratio10 Y	181.09x
PE Ratio3 Y	38.11x
PE Ratio5 Y	35.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.22%
EBITDA Margin	1.59%
FCF margin	1.75%
Gross margin	3.76%
Gross Profit	EUR 8.2B
Gross Profit Growth	19.98%
Gross Profit Growth Q	17.66%
Gross Profit Growth3 Y	12.2%
Gross Profit Growth5 Y	6.44%
Net Income	EUR 1.3B
Net Income Growth	-0.13%
Net Income Growth Q	-21.15%
Net Income Growth3 Y	49.76%
Net Income Growth5 Y	6.2%
Pretax Margin	0.8%
Profit Margin	0.62%
Profit Per Employee	EUR 24,347
ROA	3.6
Roa5y	2.74
ROCE	20.88
ROIC	80.98

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	11.81%
Cagr15y	14.45%
Cagr1y	19.66%
Cagr20y	9.81%
Cagr3y	31.31%
Cagr5y	30.09%
Div CAGR10	2.3%
Div CAGR3	-2.75%
Div CAGR5	1.09%
EPS Growth	2.48
EPS Growth Q	-19.52
EPS Growth3 Y	55.43
EPS Growth5 Y	10.85
FCF Growth	78.91%
FCF Growth Q	-39.98%
FCF Growth3 Y	-1.19%
FCF Growth5 Y	22.43%
OCF Growth	69.04%
OCF Growth Q	-37.57%
OCF Growth10 Y	4.57%
OCF Growth3 Y	0.19%
OCF Growth5 Y	20.07%
Revenue Growth	12.8x
Revenue Growth Q	11.05x
Revenue Growth3 Y	8.07x
Revenue Growth5 Y	9.88x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 4.71
Assets	EUR 49.2B
Cash	EUR 3.4B
Current Assets	EUR 32.3B
Current Liabilities	EUR 35.6B
Debt	EUR 7.7B
Debt EBITDA	EUR 2.13
Debt FCF	EUR 2.03
Equity	EUR -2.3B
Interest Coverage	10.73
Liabilities	EUR 51.5B
Long Term Assets	EUR 16.9B
Long Term Liabilities	EUR 15.9B
Net Cash	EUR -4.3B
Net Cash By Market Cap	EUR -11.82
Net Debt EBITDA	EUR 1.25
Net Debt FCF	EUR 1.14
Tangible Book Value	EUR -14.3B
Tangible Book Value Per Share	EUR -61.01

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.91
Inventory Turnover	14.13
Net Working Capital	EUR -6.2B
Quick ratio	0.42
Working Capital	EUR -3.4B
Working Capital Turnover	EUR -72.58

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.36%
Dividend Growth	-7.09%
Dividend Growth Years	1%
Dividend per share	EUR 1.75
Dividend Years	30
Dividend Yield	1.11%
Ex Div Date	2026-04-01
Last Dividend	EUR 0.44
Payout Frequency	Quarterly
Payout Ratio	30.83%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	205.31%
1Y total return	19.64%
200-day SMA	161.9
3Y total return	126.44%
50-day SMA	181.4
50-day SMA vs 200-day SMA	50over200
5Y total return	272.57%
All Time High	198.1
All Time High Change	-20.52%
All Time High Date	2026-03-02
All Time Low	17.61
All Time Low Change	794.09%
All Time Low Date	2009-09-02
ATR	3.02
Ch YTD	-10.26
High	157.5
High52	198.1
High52 Date	2026-03-02
High52ch	-20.52%
Low	157.5
Low52	124.6
Low52 Date	2025-09-23
Low52ch	26.36%
Ma50ch	-13.19%
Price vs 200-day SMA	-2.75%
RSI	28.46
RSI Monthly	58.14
RSI Weekly	41.88
Sharpe ratio	0.64x
Sortino ratio	1.29
Total Return	3.47%
Tr YTD	-9.81
Tr15y	657.69%
Tr1m	-14.2%
Tr1w	-5.06%
Tr3m	-18.62%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 2.7B
Operating Income Growth	27.81
Operating Income Growth Q	17.78
Operating Income Growth3 Y	23.19
Operating Income Growth5 Y	10.33
Operating margin	1.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	233,745,620%
Net Borrowing	969,220,566
Shares Insiders	0.09%
Shares Institutions	91.72%
Shares Qo Q	-0.42%
Shares Yo Y	-2.36%
Short Ratio	3.24

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 3.4B
Average Volume	9.25x
Bv Per Share	-10.45
CAPEX	EUR -535.1M
Ch10y	130.1
Ch15y	415.2
Ch1m	-14.2
Ch1w	-5.06
Ch1y	18.3
Ch20y	199.3
Ch3m	-18.82
Ch3y	115.4
Ch5y	231.9
Ch6m	-7.92
Change	-2.99%
Change From Open	0
Close	162.3
Days Gap	-2.99
Depreciation Amortization	783,516,888
Earnings Date	2026-04-30
EBIT	EUR 2.7B
EBITDA	EUR 3.5B
EPS	EUR 5.67
F Score	6
FCF	EUR 3.8B
FCF EV Yield	9.3x
Financing CF	-389,417,700
Fiscal Year End	June
Founded	1,979
Goodwill	9,679,486,230
Income Tax	EUR 395.5M
Investing CF	-3,411,958,200
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Date	2001-04-23
Last Split Type	Forward
Lynch Fair Value	EUR 36.04
Lynch Upside	-77.11
Ma150	172.7
Ma150ch	-8.8%
Ma20	174
Ma20ch	-9.5%
Net CF	529,920,300
Next Earnings Date	2026-08-12
Open	157.5
P FCF Ratio	9.61
P OCF Ratio	8.42
Payment Date	2026-04-15
Ppne	2,482,832,736
Price Date	2026-05-08
Price EBITDA	EUR 10.55
Relative Volume	1.75x
Revenue	217,462,465,500x
SBC By Revenue	0.18x
Share Based Comp	400,692,600
Tax By Revenue	0.18x
Tax Rate	22.75%
Tr20y	549.9%
Tr6m	-7.47%
Z Score	4.99

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/CLH dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$1.75 annual per share

Payout ratio

+30.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+1.1%

1 consecutive years of growth

Total shareholder yield

+3.5%

Next ex-dividend date: 2026-04-01

Performance

FRA/CLH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/CLH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+91.7%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/CLH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

28.5

Below 30: short-term oversold

Price vs 200-day MA

-2.8%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.64

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/CLH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/CLH stock rating?

fra/CLH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/CLH analysis?

The full report lives at /stocks/fra/CLH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/CLH?

The latest report frames fra/CLH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/CLH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.